Meet the Staff Karen Krakower Kaplan, editor of HealthLeader, brings with her 25 years of experience as both a medical writer and editor. Karen’s work has appeared in over 50 journals, magazines, newspapers and anthologies. Her additional work with AIDS organizations, organ transplant and hospice provides a necessary depth to her understanding of current health information needs.
Under her management, HealthLeader has received seven awards for outstanding writing and web design and content. Karen also leads seminars at UT Health Science Center at Houston in scientific writing, lectures on health and its impact on media, and speaks frequently in the community on various health-related topics.
Synonymous with the mission of HealthLeader, Karen strives to inform, engage and inspire readers through her work using the wealth of expertise at The UT Health Science Center at Houston.
Please feel free to email Karen at HealthLeader with suggestions, comments on stories or to request additional information on health issues.
Web designer Sophia Solis came to the Department of Institutional Advancement in 2001 with seven years experience at the University of Texas Health Science Center at Houston. She is responsible for HealthLeader’s eye-catching graphics, layout and design and content management. Under her watch, HealthLeader received the national “e-Healthcare Award” for overall excellence and The Web Marketing Association's Web award for outstanding achievement in Web site development.
Sophia is also the designer behind the sleek “look” of several other websites and publications for the UT Health Science Center at Houston. She also maintains both the content and design of several hundred of our institution’s Web pages.

FDA urges consumers
to stop
using
Zicam Nasal Spray
The US Food and Drug Administration (FDA) is alerting consumers that Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Nasal Swabs, and Zicam Cold Remedy Swabs, Kids Size, a discontinued product that consumers may still have in their homes, have all been associated with long lasting or permanent loss of smell (referred to as anosmia). These products, marketed by Matrixx Initiatives, are zinc-containing, nasal cold remedies used to reduce the duration and severity of cold symptoms. However, these products have not been shown to be effective in the reduction of the duration and severity of cold symptoms.
This advisory does not concern oral zinc tablets and lozenges taken by mouth.
FDA recommends that consumers stop using these products and throw them away. See the FDA website for How to Dispose of Unused Medicines